Anonymous
08-29-2006, 06:54 AM
I believe there is still hope for TEAMM to become a functional part of Accentia. The list of actions will not be easy to execute but at this point there is no choice.
1) Do away with the TEAMM name and call the company Accentia.
2) Bring in a senior management team that has experience building companies, raising capital, evaluating in-license opportunities and rewarding commercial success. The RTP area is filled with executives that have built small companies. While many of the executives will have ties to Glaxo, many of these people have spent a large amount of their careers building small companies. Look at a company like Salix, this company has evolved to be relatively successful. Until Accentia brings in its own management, TEAMM will always play the role of the red-headed stepchild.
3) At the same time there will need to be a very careful evaluation of the sales organization. At this point the sales team has become filled with people with a high degree of animosity toward TEAMM and its management. With the right management maybe some of these people can be turned around, but you'll need to make some hard decisions about which reps stay and which go.
4) Build a planning and budgeting infrastructure that will allow sales and marketing to grow. Develop a plan & budget and stick with it. The Finance group needs to ensure that there is money to pay for rep expenses, sales force bonuses, key suppliers and to reward exceptional performance. Right now budgeting is very lose and vendors have to fight for payment (many reps also feel that they need to fight for payment). Many suppliers are refusing to do business with us because we don't pay. Not being able to pay seems like a breakdown in budgeting.
5) This company will never be successful if it continues to point fingers. Small companies rely on everyone doing their job. Big pharma has 3-4 people doing the same job, if one person doesn't get it done the other 3 can back them up. Small pharma doesn't have this luxury. When everyone is looking to see what the other guy is doing wrong it's counter-productive to a small company's ability to grow.
6) Be patient with MD Turbo. Building a brand in this business takes time and an ongoing commitment. Everybody wants everything immediately. Sales reps want MC coverage, management want sales. This all takes time and a committed marketing effort. MC coverage does not create market demand, it removes barriers to prescribing. MC coverage is important but it won't happen overnight and neither will sales.
I feel certain this list will evoke someone to write a ridiculous response, I only hope that those that can impact change will take it seriously.
1) Do away with the TEAMM name and call the company Accentia.
2) Bring in a senior management team that has experience building companies, raising capital, evaluating in-license opportunities and rewarding commercial success. The RTP area is filled with executives that have built small companies. While many of the executives will have ties to Glaxo, many of these people have spent a large amount of their careers building small companies. Look at a company like Salix, this company has evolved to be relatively successful. Until Accentia brings in its own management, TEAMM will always play the role of the red-headed stepchild.
3) At the same time there will need to be a very careful evaluation of the sales organization. At this point the sales team has become filled with people with a high degree of animosity toward TEAMM and its management. With the right management maybe some of these people can be turned around, but you'll need to make some hard decisions about which reps stay and which go.
4) Build a planning and budgeting infrastructure that will allow sales and marketing to grow. Develop a plan & budget and stick with it. The Finance group needs to ensure that there is money to pay for rep expenses, sales force bonuses, key suppliers and to reward exceptional performance. Right now budgeting is very lose and vendors have to fight for payment (many reps also feel that they need to fight for payment). Many suppliers are refusing to do business with us because we don't pay. Not being able to pay seems like a breakdown in budgeting.
5) This company will never be successful if it continues to point fingers. Small companies rely on everyone doing their job. Big pharma has 3-4 people doing the same job, if one person doesn't get it done the other 3 can back them up. Small pharma doesn't have this luxury. When everyone is looking to see what the other guy is doing wrong it's counter-productive to a small company's ability to grow.
6) Be patient with MD Turbo. Building a brand in this business takes time and an ongoing commitment. Everybody wants everything immediately. Sales reps want MC coverage, management want sales. This all takes time and a committed marketing effort. MC coverage does not create market demand, it removes barriers to prescribing. MC coverage is important but it won't happen overnight and neither will sales.
I feel certain this list will evoke someone to write a ridiculous response, I only hope that those that can impact change will take it seriously.